Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Short Term Picks From the 'Whiz' Kid -- Ignore unavailable to you. Want to Upgrade?

To: Daniel Miller who wrote (4244)	3/8/1999 11:07:00 PM
From: Shark King	Respond to of 9115

DM, Thanks for your analysis of ANGN. The news today really does look like it has turn around potential... Thanks, Shark

To: Daniel Miller who wrote (4244)	3/9/1999 8:56:00 AM
From: Retired41	Respond to of 9115

Daniel, ANGN has a negative book value of over $6MM!! But they do have a positive current ratio. I think that with the competition in their core business, the challenges and expenses of bringing a new medical device to market, and the rate at which they burn money, the $10MM Synthelabo investment will be gone very fast (90 days) unless the get operations profitable NOW. I have no idea who Synthelabo is but I could find out if you really are interested. I also don't know if anybody knows just what ANGN's rep is in the cardiac business. I have a cardiologist buddy that I could ask if you are interested. But beware he probably won't really be able to talk until the weekend. I think that this could be a short if it runs for a few more days and gets higher than $2.25. WIth that said, I have no confidence that it will progress above where it closed yesterday. I'd rather go to Vegas and get a free drink with my bet.